Edition:
United States

miRagen Therapeutics Inc (MGEN.OQ)

MGEN.OQ on NASDAQ Stock Exchange Capital Market

3.64USD
3:59pm EST
Change (% chg)

$0.02 (+0.55%)
Prev Close
$3.62
Open
$3.67
Day's High
$3.91
Day's Low
$3.56
Volume
28,996
Avg. Vol
31,714
52-wk High
$10.68
52-wk Low
$3.54

Chart for

About

Miragen Therapeutics, Inc., formerly Signal Genetics, Inc., is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing ribonucleic acid (RNA)-targeted therapeutics with a specific focus on microRNAs and their role in diseases where there is a high unmet medical need. Its clinical product... (more)

Overall

Beta: 1.48
Market Cap(Mil.): $111.64
Shares Outstanding(Mil.): 30.84
Dividend: --
Yield (%): --

Financials

  MGEN.OQ Industry Sector
P/E (TTM): -- 81.01 29.57
EPS (TTM): -1.04 -- --
ROI: -52.19 -0.53 12.77
ROE: -57.72 -3.22 14.47

Earnings vs. Estimates